MNDL Bio
PrivateLast Round
Seed
Sep 8, 2024
Total Funding Raised
$2.1M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
MNDL Bio operates in Healthcare & Life Sciences and is based in Tel Aviv. Its latest recorded funding round was a Seed round in September 2024.
MNDL Bio is a synthetic biology company that provides an AI-powered computational platform to optimize gene expression for recombinant protein production.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
MNDL Bio Comparables
Compare MNDL Bio with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Avenue Biosciences | 82% | |
| Scala Biodesign | 82% | |
| ExpressionEdits | 81% |
For institutional investors. Book with your work email.
MNDL Bio Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Seed | Sep 8, 2024 | ||||
| Grant | Jul 1, 2023 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
MNDL Bio Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Israel Innovation Authority | Seed |
| CPT Capital | Seed |
| Earth & Beyond Ventures | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 25, 2026
Grew 40% QoQ, from 10 to 14 employees.
- Jul 17, 2026
Grew 50% QoQ, from 10 to 15 employees.
For institutional investors. Book with your work email.
MNDL Bio Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about MNDL Bio's valuation, stock price, and market status.
Is MNDL Bio a public or private company?
MNDL Bio is a private company.
What is the current stock price of MNDL Bio?
MNDL Bio is a private company, so its shares have no public market price. Caplight tracks MNDL Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is MNDL Bio worth (valuation)?
Valuation information for MNDL Bio is not publicly available.
Can I buy MNDL Bio stock?
MNDL Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was MNDL Bio's last funding round?
MNDL Bio's most recent funding round was Seed on September 8, 2024.
Who are the main investors in MNDL Bio?
Key investors in MNDL Bio include Earth & Beyond Ventures.
Will MNDL Bio IPO soon?
No public IPO plans have been announced for MNDL Bio.
How can I track MNDL Bio secondary market activity?
Caplight tracks bids, offers, and trades in MNDL Bio's shares on secondary markets.